Publications by authors named "C E Hirst"

In vivo in infection, virions are constantly produced and die rapidly. In contrast, most antibody binding assays do not include such features. Motivated by this, we considered virions with n = 100 binding sites in simple mathematical models with and without the production of virions.

View Article and Find Full Text PDF

The ice-covered period of large Arctic rivers is shortening. To what extent will this affect biogeochemical processing of nutrients? Here we reveal, with silicon isotopes (δSi), a key winter pathway for nutrients under river ice. During colder winter phases in the Lena River catchment, conditions are met for frazil ice accumulation, which creates microzones.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed data from 7,070 patients with cardiogenic shock (CS), finding that 5.6% developed acute limb ischemia (ALI), particularly among women and those with peripheral arterial disease.* -
  • ALI incidence increased with the severity of CS, with highest rates among patients using advanced support devices like VA-ECMO and balloon pumps, yet less than half used distal perfusion catheters.* -
  • Mortality rates were significantly higher for patients with ALI (57.4%) compared to those without (38.0%), highlighting ALI's severe impact on survival in CS patients.*
View Article and Find Full Text PDF

In vivo in infection, virions are constantly produced and die rapidly. In contrast, most antibody binding assays do not include such features. Motivated by this, we considered virions with n=100 binding sites in simple mathematical models with and without the production of virions.

View Article and Find Full Text PDF

Objective: Non-adherence to adjuvant endocrine therapy (AET) in women with breast cancer is common and associated with medication side-effects and distress. We co-designed an Acceptance and Commitment Therapy intervention (ACTION) to enhance medication decision-making and quality of life (QoL). We undertook a pilot trial of ACTION to inform the feasibility of a phase III trial, and to examine intervention acceptability.

View Article and Find Full Text PDF